Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit Rises
02/11/2023 08:07
Nov 2 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* SEPT-QUARTER CONSOL NET PROFIT 1.09 BILLION RUPEES VERSUS
PROFIT
717 MILLION RUPEES YEAR AGO
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 6.01 BILLION
RUPEES
VERSUS 5.34 BILLION RUPEES YEAR AGO
Further company coverage: DLPA.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise